Amylyx Pharmaceuticals, Inc. (AMLX)
AMLX Stock Price Chart
Explore Amylyx Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze AMLX price movements and trends.
AMLX Company Profile
Discover essential business fundamentals and corporate details for Amylyx Pharmaceuticals, Inc. (AMLX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
7 Jan 2022
Employees
123.00
Website
https://amylyx.comCEO
Joshua Cohen
Description
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.
AMLX Financial Timeline
Browse a chronological timeline of Amylyx Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.36.
Earnings released on 7 May 2026
EPS came in at -$0.37 falling short of the estimated -$0.34 by -8.82%.
Earnings released on 3 Mar 2026
EPS came in at -$0.30 surpassing the estimated -$0.31 by +3.23%.
Earnings released on 6 Nov 2025
EPS came in at -$0.37 surpassing the estimated -$0.43 by +13.95%.
Earnings released on 7 Aug 2025
EPS came in at -$0.46 falling short of the estimated -$0.44 by -4.55%.
Earnings released on 8 May 2025
EPS came in at -$0.42 surpassing the estimated -$0.45 by +6.67%.
Earnings released on 4 Mar 2025
EPS came in at -$0.55 falling short of the estimated -$0.49 by -12.24%, while revenue for the quarter reached $665.00k .
Earnings released on 7 Nov 2024
EPS came in at -$0.53 falling short of the estimated -$0.47 by -12.77%, while revenue for the quarter reached $416.00k .
Earnings released on 8 Aug 2024
EPS came in at -$0.73 falling short of the estimated -$0.38 by -92.11%, while revenue for the quarter reached $1.02m , missing expectations by -90.41%.
Earnings released on 9 May 2024
EPS came in at -$0.46 falling short of the estimated $0.24 by -291.67%, while revenue for the quarter reached $88.64m , missing expectations by -9.87%.
Earnings released on 22 Feb 2024
EPS came in at $0.07 falling short of the estimated $0.23 by -69.57%, while revenue for the quarter reached $108.45m , beating expectations by +1.39%.
Earnings released on 9 Nov 2023
EPS came in at $0.30 falling short of the estimated $0.44 by -31.82%, while revenue for the quarter reached $102.69m , missing expectations by -4.78%.
Earnings released on 10 Aug 2023
EPS came in at $0.31 surpassing the estimated $0.10 by +210.00%, while revenue for the quarter reached $98.22m , beating expectations by +6.63%.
Earnings released on 11 May 2023
EPS came in at $0.02 surpassing the estimated -$0.24 by +108.33%, while revenue for the quarter reached $71.43m , missing expectations by -18.47%.
Earnings released on 13 Mar 2023
EPS came in at -$0.65 surpassing the estimated -$0.77 by +15.58%, while revenue for the quarter reached $21.89m , missing expectations by -62.90%.
Earnings released on 10 Nov 2022
EPS came in at -$0.92 surpassing the estimated -$0.97 by +5.15%, while revenue for the quarter reached $345.00k , beating expectations by +314.00%.
Earnings released on 11 Aug 2022
EPS came in at -$0.93 falling short of the estimated -$0.92 by -1.09%.
Earnings released on 12 May 2022
EPS came in at -$0.93 falling short of the estimated -$0.75 by -24.00%.
Earnings released on 30 Mar 2022
EPS came in at -$4.15 falling short of the estimated -$0.64 by -548.44%.
Earnings released on 10 Jan 2022
EPS came in at -$0.42 , while revenue for the quarter reached $285.00k .
AMLX Stock Performance
Access detailed AMLX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
